Skip to main content

Find Clinical Trials

Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

367 public trials 125 recruiting studies

Refine in advanced search Browse all conditions

NSCLC trial results

Not yet recruiting

Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer

NCT07379398

Conditions: NSCLC
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not yet recruiting

Relatrilfa-α Plus Single-Agent Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III NSCLC (Phase 2)

NCT07550920

Conditions: NSCLC
Locations: Not specified

View Trial Details

Not yet recruiting

Post-Market Registry of Transbronchial Cryo-assisted RFA During Routine Standard Bronchoscopic Tumor Stagng and Resection

NCT07530744

Conditions: Cryotherapy, NSCLC, RFA
Locations: Ordensklinikum Linz Elisabethinen Linz, Austria

View Trial Details

Not yet recruiting

Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC

NCT07516015

Conditions: NSCLC
Locations: Not specified

View Trial Details

Not yet recruiting

Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer

NCT06552000

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: The University of Texas Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Not yet recruiting

Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases

NCT07413952

Conditions: NSCLC
Locations: The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Guangzhou, China

View Trial Details

Not yet recruiting

Iruplinalkib Tablets as Postoperative Adjuvant Therapy in Stage IA ALK-positive NSCLC With High-risk Factors

NCT07330076

Conditions: NSCLC
Locations: Not specified

View Trial Details

Not yet recruiting

Stereotactic Body Radiotherapy With Sequential Iparomlimab and Tuvonralimab (QL1706) + Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Non-small-cell Lung Cancer in China (LUNG-Nanjing01): a Single-arm, Single-centre, Phase 2 Trial

NCT07286942

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Jiangsu Cancer Hospital Nanjing, Jiangsu, China

View Trial Details

Not yet recruiting

A Study of SHR-A1811 Combined With Adebelimumab as Neoadjuvant Therapy for Resectable HER2-Altered Non-Small Cell Lung Cancer

NCT07281209

Conditions: NSCLC
Locations: Not specified

View Trial Details

Not yet recruiting

Influence of a PSychological Intensive Support Program for Lung Cancer Patients ON Post-operative Outcomes.

NCT07260227

Conditions: Anxiety Postoperative, Behavior, Behavioral Symptoms, +2 more
Locations: Not specified

View Trial Details